NDC 23359-100

Centratex

Iron, Sodium Ascorbate, Thiamine Mononitrate, Riboflavin, Pyridoxine Hydrochloride, Folic Acid, Cyanocobalamin, Niacinamide, Calcium Pantothenate, Zinc Sulfate, Magnesium Sulfate, Manganese Sulfate, A

Centratex is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Centurion Labs. The primary component is Iron; Sodium Ascorbate; Thiamine Mononitrate; Riboflavin; Pyridoxine Hydrochloride; Folic Acid; Cyanocobalamin; Niacinamide; Calcium Pantothenate; Zinc Sulfate; Magnesium Sulfate; Manganese Sulfate; Cupric Sulfate Anhydrous.

Product ID23359-100_00a6e59a-4714-46ab-8119-12db89deff27
NDC23359-100
Product TypeHuman Prescription Drug
Proprietary NameCentratex
Generic NameIron, Sodium Ascorbate, Thiamine Mononitrate, Riboflavin, Pyridoxine Hydrochloride, Folic Acid, Cyanocobalamin, Niacinamide, Calcium Pantothenate, Zinc Sulfate, Magnesium Sulfate, Manganese Sulfate, A
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2009-06-14
Marketing CategoryUNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
Labeler NameCenturion Labs
Substance NameIRON; SODIUM ASCORBATE; THIAMINE MONONITRATE; RIBOFLAVIN; PYRIDOXINE HYDROCHLORIDE; FOLIC ACID; CYANOCOBALAMIN; NIACINAMIDE; CALCIUM PANTOTHENATE; ZINC SULFATE; MAGNESIUM SULFATE; MANGANESE SULFATE; CUPRIC SULFATE ANHYDROUS
Active Ingredient Strength106 mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; ug/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1
Pharm ClassesOsmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Vitamin B6 Analog [EPC],Vitamin B 6 [Chemical/Ingredient],Analogs/Derivatives [Chemical/Ingredient],Vitamin B 12 [CS],Vitamin B12 [EPC],Copper [CS],Copper-containing Intrauterine Device [EPC],Decreased Embryonic Implantation [PE],Decreased Sperm Motility [PE],Inhibit Ovum Fertilization [PE]
NDC Exclude FlagE
Listing Certified Through2017-12-31

Packaging

NDC 23359-100-10

100 CAPSULE in 1 BOTTLE (23359-100-10)
Marketing Start Date2009-06-14
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 23359-100-30 [23359010030]

Centratex CAPSULE
Marketing CategoryUnapproved drug other
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2009-06-14
Inactivation Date2019-10-21
Reactivation Date2019-12-20

NDC 23359-100-10 [23359010010]

Centratex CAPSULE
Marketing CategoryUnapproved drug other
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2009-06-14
Inactivation Date2019-10-21
Reactivation Date2019-12-20

Drug Details

Active Ingredients

IngredientStrength
IRON106 mg/1

OpenFDA Data

SPL SET ID:4d4d823b-ff2f-4746-9bd7-44def2b81347
Manufacturer
UNII

Pharmacological Class

  • Osmotic Laxative [EPC]
  • Increased Large Intestinal Motility [PE]
  • Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]
  • Osmotic Activity [MoA]
  • Vitamin B6 Analog [EPC]
  • Vitamin B 6 [Chemical/Ingredient]
  • Analogs/Derivatives [Chemical/Ingredient]
  • Vitamin B 12 [CS]
  • Vitamin B12 [EPC]
  • Copper [CS]
  • Copper-containing Intrauterine Device [EPC]
  • Decreased Embryonic Implantation [PE]
  • Decreased Sperm Motility [PE]
  • Inhibit Ovum Fertilization [PE]

Medicade Reported Pricing

23359010030 CENTRATEX CAPSULE

Pricing Unit: EA | Drug Type:

23359010010 CENTRATEX CAPSULE

Pricing Unit: EA | Drug Type:

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.